Looking for volunteers
Robotic Systems Evaluation for Peripheral Pulmonary Lesions (RISE Trial)
NCT07735611 · Case Comprehensive Cancer Center · Updated 21 Oct 2026
- What is being tested
- RAB via the Monarch platform; RAB via the ION platform
- For
- Lung; Node
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 398 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started Oct 2026, ends Aug 2027. Registered 30 July 2026.
- Results
- None posted yet.
In the researchers' words
This is an investigator-initiated cluster randomized control trial. The primary objective is to compare the diagnostic yield of two Food and Drug Administration (FDA) cleared national robotic assisted bronchoscopy platforms - the Monarch™ Platform and the ION™ Endoluminal System - in participants undergoing bronchoscopy to evaluate peripheral pulmonary lesions (PPLs). Participants will undergo their scheduled robotic assisted bronchoscopy (RAB) using one of these platforms.
Sites
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer CenterCleveland, Ohio, United States